Crescita Therapeutics Inc. (TSX:CTX)

Crescita Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	8.71	8.58	9.27	9.39	8.24	11.33
Short-Term Investments	-	0	0	0	0.07	0.08
Cash & Short-Term Investments	8.71	8.58	9.28	9.39	8.31	11.41
Cash Growth	2.02%	-7.50%	-1.19%	12.97%	-27.17%	-20.44%
Accounts Receivable	2.55	2.08	1.58	2.75	6.14	3.6
Other Receivables	-	0.03	0.13	0.02	0.1	0.15
Receivables	2.55	2.11	1.72	2.78	6.24	3.75
Inventory	4.17	4.72	4.05	6.13	5.65	4.39
Prepaid Expenses	-	0.3	0.26	0.2	0.32	0.54
Other Current Assets	0.37	-	-	-	-	-
Total Current Assets	15.8	15.72	15.3	18.49	20.52	20.09
Property, Plant & Equipment	3.75	1.79	2.42	1.85	2.31	2.58
Long-Term Investments	-	-	0.31	0.36	0.34	0.34
Other Intangible Assets	1.3	1.46	1.74	1.99	2.87	3.74
Long-Term Accounts Receivable	1.33	1.36	1.39	1.48	1.57	1.66
Long-Term Deferred Tax Assets	-	-	-	-	0.46	-
Total Assets	22.18	20.33	21.78	24.6	28.48	28.92

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	5.17	4.34	5	4.33	5.59	5.33
Current Portion of Long-Term Debt	-	-	-	-	-	0.98
Current Portion of Leases	0.41	0.33	0.47	0.44	0.41	0.37
Other Current Liabilities	0.05	0.05	0.05	0.1	0.06	0.06
Total Current Liabilities	5.64	4.72	5.52	4.86	6.06	6.73
Long-Term Leases	2.09	-	0.37	0.82	1.21	1.53
Other Long-Term Liabilities	0.04	0.03	0.07	0.1	0.12	0.15
Total Liabilities	7.76	4.75	5.95	5.78	7.39	8.4

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	51.49	51.49	52.7	54.34	56.3	58.08
Additional Paid-In Capital	8.42	8.41	7.37	5.96	4.27	2.77
Retained Earnings	-46.6	-45.44	-45.35	-42.6	-40.61	-41.48
Comprehensive Income & Other	1.12	1.12	1.11	1.12	1.13	1.15
Shareholders' Equity	14.42	15.58	15.83	18.82	21.1	20.53
Total Liabilities & Equity	22.18	20.33	21.78	24.6	28.48	28.92

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	2.5	0.33	0.83	1.25	1.61	2.87
Net Cash (Debt)	6.21	8.25	8.44	8.13	6.7	8.54
Net Cash Growth	-20.60%	-2.32%	3.79%	21.46%	-21.60%	-34.85%
Net Cash Per Share	0.33	0.44	0.44	0.40	0.32	0.41
Filing Date Shares Outstanding	18.61	18.61	19.01	19.54	20.33	20.9
Total Common Shares Outstanding	18.61	18.61	19.08	19.96	20.33	20.98
Working Capital	10.17	11	9.79	13.62	14.46	13.37
Book Value Per Share	0.77	0.84	0.83	0.94	1.04	0.98
Tangible Book Value	13.13	14.12	14.09	16.83	18.23	16.79
Tangible Book Value Per Share	0.71	0.76	0.74	0.84	0.90	0.80
Machinery	-	3.8	3.59	2.68	2.56	2.32
Leasehold Improvements	-	0.64	0.62	0.62	0.62	0.62

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 7, 2026

Data Sources Report a data error